Skip to content
inSoma Bio logo

inSoma Bio

inSoma Bio is a YC Summer 2020 (S20) company. Based in Durham, NC, USA. Team of 4.

  • Synthetic Biology
  • Medical Devices

About inSoma Bio

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

inSoma Bio develops injectable biomaterials for reconstructive plastic surgery, targeting procedures such as breast and facial reconstruction. Its core product, the Fractomer Biomatrix, is a recombinant protein-based material that supports a patient's own transplanted cells or tissue, replacing synthetic implants and fillers. Surgeons gain a bio-integrated scaffold produced at the genetic level, activated only at body temperature, without harvesting donor tissue.

Go-to-market

Plastic surgeons are the direct customer, reached through clinical and academic medical channels, with Duke University and advisory relationships at major surgical departments anchoring early adoption.

From the Y Combinator listing

How inSoma Bio describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Helping Plastic Surgeons Rebuild Fat

Facts

Industry
Healthcare / Healthcare -> Medical Devices
Location
Durham, NC, USA
Team size
4
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works